Genesis Therapeutics

We’re a hybrid AI + biotech start-up, developing novel neural networks to predict molecular properties and using them to accelerate the development of new medicines. Looking for great software engineers and ML researchers with an interest in drug discovery -- no biology or chemistry experience required. We all learn from each other here. - We currently have a small team of excellent AI + software engineers: graduates from Stanford, UC Berkeley, MIT. Previously worked at Facebook, Google, Memsql, Jane Street - Core deep learning tech was invented by co-founder + CEO Evan Feinberg during his PhD at Stanford’s Pande lab (the lab that did Folding@Home). See the peer-reviewed PotentialNet paper: - Seed round led by Andreessen Horowitz, and we currently have lots of runway - Our platform was validated in collaboration with a top-five pharma company, in a public paper: - In addition to strong software + AI talent, our small team has top drug discovery chemists who have collectively discovered several FDA-approved drugs before